Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 64,864 | 68,481 | 45,871 | 37,958 | 20,042 |
| Cost of Goods | 2,633 | 2,706 | 2,100 | 1,279 | 885 |
| Gross Profit | 62,231 | 65,775 | 43,771 | 36,679 | 19,157 |
| Operating Expenses | 97,066 | 129,029 | 101,297 | 106,311 | 103,799 |
| Operating Income | -34,202 | -62,548 | -57,426 | -69,353 | -83,757 |
| Interest Expense | 11,846 | 10,870 | 8,283 | 7,858 | 8,051 |
| Other Income | 3,375 | 5,404 | 4,994 | 5,364 | 6,962 |
| Pre-tax Income | -42,673 | -68,014 | -60,715 | -71,847 | -84,846 |
| Net Income Continuous | -42,673 | -68,014 | -60,715 | -71,847 | -84,846 |
| Net Income | $-42,673 | $-68,014 | $-60,715 | $-71,847 | $-84,846 |
| EPS Basic Total Ops | -0.48 | -0.78 | -0.70 | -0.83 | -0.98 |
| EPS Basic Continuous Ops | -0.48 | -0.78 | -0.70 | -0.83 | -0.98 |
| EPS Diluted Total Ops | -0.48 | -0.78 | -0.70 | -0.83 | -0.98 |
| EPS Diluted Continuous Ops | -0.48 | -0.78 | -0.70 | -0.83 | -0.98 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.78 | -0.70 | -0.83 | -0.98 |
| EBITDA(a) | $-34,874 | $-64,076 | $-59,774 | $-72,730 | $-87,023 |